retinoic acid Search Results


95
MedChemExpress retinoic acid
Retinoic Acid, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/retinoic acid/product/MedChemExpress
Average 95 stars, based on 1 article reviews
retinoic acid - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

96
Tocris density
Density, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/density/product/Tocris
Average 96 stars, based on 1 article reviews
density - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology all trans retinoic acid
Fig. 7. Cellular effects of ATRA or irinotecan in combination with 680C91 in neuroblastoma. Working model of the mechanism of action of the chemotherapeutic agents ATRA and irinotecan along with inhibitors of the Kyn-AHR pathway in neuroblastoma. RAR: <t>Retinoic</t> Acid Receptor. AHR can be activated by Kyn and ATRA in neuroblastoma cells leading to the transcriptional activation of AHR transcriptional signature. Inhibiting Kyn production synergizes with ATRA and irinotecan to inhibit neuroblastoma cell growth.
All Trans Retinoic Acid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/all trans retinoic acid/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
all trans retinoic acid - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

96
Tocris retinoic acid peproech
Fig. 7. Cellular effects of ATRA or irinotecan in combination with 680C91 in neuroblastoma. Working model of the mechanism of action of the chemotherapeutic agents ATRA and irinotecan along with inhibitors of the Kyn-AHR pathway in neuroblastoma. RAR: <t>Retinoic</t> Acid Receptor. AHR can be activated by Kyn and ATRA in neuroblastoma cells leading to the transcriptional activation of AHR transcriptional signature. Inhibiting Kyn production synergizes with ATRA and irinotecan to inhibit neuroblastoma cell growth.
Retinoic Acid Peproech, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/retinoic acid peproech/product/Tocris
Average 96 stars, based on 1 article reviews
retinoic acid peproech - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

95
Thermo Fisher trans retinoic acid
Fig. 7. Cellular effects of ATRA or irinotecan in combination with 680C91 in neuroblastoma. Working model of the mechanism of action of the chemotherapeutic agents ATRA and irinotecan along with inhibitors of the Kyn-AHR pathway in neuroblastoma. RAR: <t>Retinoic</t> Acid Receptor. AHR can be activated by Kyn and ATRA in neuroblastoma cells leading to the transcriptional activation of AHR transcriptional signature. Inhibiting Kyn production synergizes with ATRA and irinotecan to inhibit neuroblastoma cell growth.
Trans Retinoic Acid, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/trans retinoic acid/product/Thermo Fisher
Average 95 stars, based on 1 article reviews
trans retinoic acid - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

91
TargetMol 13 cis retinoic acid
Fig. 7. Cellular effects of ATRA or irinotecan in combination with 680C91 in neuroblastoma. Working model of the mechanism of action of the chemotherapeutic agents ATRA and irinotecan along with inhibitors of the Kyn-AHR pathway in neuroblastoma. RAR: <t>Retinoic</t> Acid Receptor. AHR can be activated by Kyn and ATRA in neuroblastoma cells leading to the transcriptional activation of AHR transcriptional signature. Inhibiting Kyn production synergizes with ATRA and irinotecan to inhibit neuroblastoma cell growth.
13 Cis Retinoic Acid, supplied by TargetMol, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/13 cis retinoic acid/product/TargetMol
Average 91 stars, based on 1 article reviews
13 cis retinoic acid - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

93
MedChemExpress isotretinoin
Fig. 7. Cellular effects of ATRA or irinotecan in combination with 680C91 in neuroblastoma. Working model of the mechanism of action of the chemotherapeutic agents ATRA and irinotecan along with inhibitors of the Kyn-AHR pathway in neuroblastoma. RAR: <t>Retinoic</t> Acid Receptor. AHR can be activated by Kyn and ATRA in neuroblastoma cells leading to the transcriptional activation of AHR transcriptional signature. Inhibiting Kyn production synergizes with ATRA and irinotecan to inhibit neuroblastoma cell growth.
Isotretinoin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/isotretinoin/product/MedChemExpress
Average 93 stars, based on 1 article reviews
isotretinoin - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology cis retinoic acid d 3
Fig. 7. Cellular effects of ATRA or irinotecan in combination with 680C91 in neuroblastoma. Working model of the mechanism of action of the chemotherapeutic agents ATRA and irinotecan along with inhibitors of the Kyn-AHR pathway in neuroblastoma. RAR: <t>Retinoic</t> Acid Receptor. AHR can be activated by Kyn and ATRA in neuroblastoma cells leading to the transcriptional activation of AHR transcriptional signature. Inhibiting Kyn production synergizes with ATRA and irinotecan to inhibit neuroblastoma cell growth.
Cis Retinoic Acid D 3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cis retinoic acid d 3/product/Santa Cruz Biotechnology
Average 94 stars, based on 1 article reviews
cis retinoic acid d 3 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

93
Boster Bio chemerin
Fig. 7. Cellular effects of ATRA or irinotecan in combination with 680C91 in neuroblastoma. Working model of the mechanism of action of the chemotherapeutic agents ATRA and irinotecan along with inhibitors of the Kyn-AHR pathway in neuroblastoma. RAR: <t>Retinoic</t> Acid Receptor. AHR can be activated by Kyn and ATRA in neuroblastoma cells leading to the transcriptional activation of AHR transcriptional signature. Inhibiting Kyn production synergizes with ATRA and irinotecan to inhibit neuroblastoma cell growth.
Chemerin, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chemerin/product/Boster Bio
Average 93 stars, based on 1 article reviews
chemerin - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Boster Bio mouse chemerin elisa kit
The effects of different concentrations of <t>chemerin</t> on ROS level, T-AOC and glucose uptake in the high glucose cell model. ( A ) The relative fluorescence intensity of ROS. ( B ) The detection of total antioxidant capacity. ( C ) The intake of glucose by cells. HG: high glucose; ROS: reactive oxygen species; T-AOC: total antioxidant capacity. Data were shown as mean ± SD ( n ≥ 3). * P < 0.05; ** P < 0.01
Mouse Chemerin Elisa Kit, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse chemerin elisa kit/product/Boster Bio
Average 93 stars, based on 1 article reviews
mouse chemerin elisa kit - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

85
LKT Laboratories cis
The effects of different concentrations of <t>chemerin</t> on ROS level, T-AOC and glucose uptake in the high glucose cell model. ( A ) The relative fluorescence intensity of ROS. ( B ) The detection of total antioxidant capacity. ( C ) The intake of glucose by cells. HG: high glucose; ROS: reactive oxygen species; T-AOC: total antioxidant capacity. Data were shown as mean ± SD ( n ≥ 3). * P < 0.05; ** P < 0.01
Cis, supplied by LKT Laboratories, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cis/product/LKT Laboratories
Average 85 stars, based on 1 article reviews
cis - by Bioz Stars, 2026-03
85/100 stars
  Buy from Supplier

93
Proteintech rara proteintech
The effects of different concentrations of <t>chemerin</t> on ROS level, T-AOC and glucose uptake in the high glucose cell model. ( A ) The relative fluorescence intensity of ROS. ( B ) The detection of total antioxidant capacity. ( C ) The intake of glucose by cells. HG: high glucose; ROS: reactive oxygen species; T-AOC: total antioxidant capacity. Data were shown as mean ± SD ( n ≥ 3). * P < 0.05; ** P < 0.01
Rara Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rara proteintech/product/Proteintech
Average 93 stars, based on 1 article reviews
rara proteintech - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


Fig. 7. Cellular effects of ATRA or irinotecan in combination with 680C91 in neuroblastoma. Working model of the mechanism of action of the chemotherapeutic agents ATRA and irinotecan along with inhibitors of the Kyn-AHR pathway in neuroblastoma. RAR: Retinoic Acid Receptor. AHR can be activated by Kyn and ATRA in neuroblastoma cells leading to the transcriptional activation of AHR transcriptional signature. Inhibiting Kyn production synergizes with ATRA and irinotecan to inhibit neuroblastoma cell growth.

Journal: The FEBS journal

Article Title: Targeting of neuroblastoma cells through Kynurenine-AHR pathway inhibition.

doi: 10.1111/febs.17109

Figure Lengend Snippet: Fig. 7. Cellular effects of ATRA or irinotecan in combination with 680C91 in neuroblastoma. Working model of the mechanism of action of the chemotherapeutic agents ATRA and irinotecan along with inhibitors of the Kyn-AHR pathway in neuroblastoma. RAR: Retinoic Acid Receptor. AHR can be activated by Kyn and ATRA in neuroblastoma cells leading to the transcriptional activation of AHR transcriptional signature. Inhibiting Kyn production synergizes with ATRA and irinotecan to inhibit neuroblastoma cell growth.

Article Snippet: Drugs included CH-223191 (Cayman, 16154, Ann Arbor, MI, USA), all-Trans Retinoic Acid (Santa Cruz, SC-200898A, Dallas, TX, USA), irinotecan (Santa Cruz, sc-269253), epacadostat (Medchem Express, HY-15689, Monmouth Junction, NJ, USA), 680C91 (Sigma, SML0287).

Techniques: Activation Assay

The effects of different concentrations of chemerin on ROS level, T-AOC and glucose uptake in the high glucose cell model. ( A ) The relative fluorescence intensity of ROS. ( B ) The detection of total antioxidant capacity. ( C ) The intake of glucose by cells. HG: high glucose; ROS: reactive oxygen species; T-AOC: total antioxidant capacity. Data were shown as mean ± SD ( n ≥ 3). * P < 0.05; ** P < 0.01

Journal: Molecular Medicine

Article Title: Chemerin alleviates the placental oxidative stress and improves fetal overgrowth of gestational diabetes mellitus mice induced by high fat diet

doi: 10.1186/s10020-024-01007-2

Figure Lengend Snippet: The effects of different concentrations of chemerin on ROS level, T-AOC and glucose uptake in the high glucose cell model. ( A ) The relative fluorescence intensity of ROS. ( B ) The detection of total antioxidant capacity. ( C ) The intake of glucose by cells. HG: high glucose; ROS: reactive oxygen species; T-AOC: total antioxidant capacity. Data were shown as mean ± SD ( n ≥ 3). * P < 0.05; ** P < 0.01

Article Snippet: Fasting insulin levels were measured using a mouse insulin ELISA kit (P01325, RayBiotech Life, USA) and the content of chemerin was assayed by the mouse chemerin ELISA kit (EK1330, Boster Biological Technology, China), assays were both according to the manufacturer’s protocols.

Techniques: Fluorescence

The effects of chemerin on the glucose tolerance, weight of fetal mice and placentas, fasting insulin levels, lipid metabolism and liver function. ( A ) The blood glucose of pregnant mice detected by IPGTT on D16.5 (* represents the comparison between the chow groups and the HFD groups; # represents the comparison between the HFD groups and the treated groups). ( B ) The body weight of fetal mice on D18.5. ( C ) The weight of mice placentas on D18.5. ( D ) The sizes of fetal mice and placentas on D18.5 after chemerin treatment. ( E ) The serum level of chemerin on D18.5. ( F ) The serum level of fasting insulin on D18.5. ( G ) The serum level of ALT on D18.5. ( H ) The serum level of AST on D18.5. ( I ) The serum level of HDL on D18.5. ( J ) The serum level of LDL on D18.5. ( K ) The serum level of TC on D18.5. ( L ) The serum level of TG on D18.5. HFD: high fat diet; FINS: fasting insulin; ALT: alanine aminotransferase; AST: aspartate transaminase; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TC: total cholesterol; TG: triglyceride. Data were shown as mean ± SD ( n ≥ 3). # P < 0.05; * P < 0.05; ** P < 0.01; *** P < 0.001

Journal: Molecular Medicine

Article Title: Chemerin alleviates the placental oxidative stress and improves fetal overgrowth of gestational diabetes mellitus mice induced by high fat diet

doi: 10.1186/s10020-024-01007-2

Figure Lengend Snippet: The effects of chemerin on the glucose tolerance, weight of fetal mice and placentas, fasting insulin levels, lipid metabolism and liver function. ( A ) The blood glucose of pregnant mice detected by IPGTT on D16.5 (* represents the comparison between the chow groups and the HFD groups; # represents the comparison between the HFD groups and the treated groups). ( B ) The body weight of fetal mice on D18.5. ( C ) The weight of mice placentas on D18.5. ( D ) The sizes of fetal mice and placentas on D18.5 after chemerin treatment. ( E ) The serum level of chemerin on D18.5. ( F ) The serum level of fasting insulin on D18.5. ( G ) The serum level of ALT on D18.5. ( H ) The serum level of AST on D18.5. ( I ) The serum level of HDL on D18.5. ( J ) The serum level of LDL on D18.5. ( K ) The serum level of TC on D18.5. ( L ) The serum level of TG on D18.5. HFD: high fat diet; FINS: fasting insulin; ALT: alanine aminotransferase; AST: aspartate transaminase; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TC: total cholesterol; TG: triglyceride. Data were shown as mean ± SD ( n ≥ 3). # P < 0.05; * P < 0.05; ** P < 0.01; *** P < 0.001

Article Snippet: Fasting insulin levels were measured using a mouse insulin ELISA kit (P01325, RayBiotech Life, USA) and the content of chemerin was assayed by the mouse chemerin ELISA kit (EK1330, Boster Biological Technology, China), assays were both according to the manufacturer’s protocols.

Techniques: Comparison

The localization and expressions of chemerin and DsbA-L in mice placenta of the HFD groups and the chow groups. ( A ) Staining of chemerin and DsbA-L by immunohistochemistry (scale bar = 100 μm). ( B ) Western blotting images of mice placentas. ( C ) Protein quantification of chemerin relative to β-actin. ( D ) AOD of chemerin in mice placenta. ( E ) AOD of DsbA-L in mice placenta. DsbA-L: disulfide-bond A oxidoreductase-like protein; HFD: high fat diet; LA: labyrinth; JZ: junctional zone; AOD: average optical density. Data were shown as mean ± SD ( n ≥ 3). ** P < 0.01, **** P < 0.0001

Journal: Molecular Medicine

Article Title: Chemerin alleviates the placental oxidative stress and improves fetal overgrowth of gestational diabetes mellitus mice induced by high fat diet

doi: 10.1186/s10020-024-01007-2

Figure Lengend Snippet: The localization and expressions of chemerin and DsbA-L in mice placenta of the HFD groups and the chow groups. ( A ) Staining of chemerin and DsbA-L by immunohistochemistry (scale bar = 100 μm). ( B ) Western blotting images of mice placentas. ( C ) Protein quantification of chemerin relative to β-actin. ( D ) AOD of chemerin in mice placenta. ( E ) AOD of DsbA-L in mice placenta. DsbA-L: disulfide-bond A oxidoreductase-like protein; HFD: high fat diet; LA: labyrinth; JZ: junctional zone; AOD: average optical density. Data were shown as mean ± SD ( n ≥ 3). ** P < 0.01, **** P < 0.0001

Article Snippet: Fasting insulin levels were measured using a mouse insulin ELISA kit (P01325, RayBiotech Life, USA) and the content of chemerin was assayed by the mouse chemerin ELISA kit (EK1330, Boster Biological Technology, China), assays were both according to the manufacturer’s protocols.

Techniques: Staining, Immunohistochemistry, Western Blot

The roles and mechanisms of chemerin in the placental oxidative stress and insulin resistance in HFD pregnant mice. ( A ) Western blotting images of mice placentas of three groups. ( B ) Western blotting images of mice placentas between the chow groups and the HFD groups. ( C ) Western blotting images of mice placentas between the HFD groups and the treated groups. The HFD placenta samples presented in ( B ) and ( C ) were from the same several mice. ( D ) Protein quantification of AKT relative to β-actin. ( E ) Protein quantification of IRS1 relative to β-actin. ( F ) Protein quantification of STING relative to β-actin. ( G ) Protein quantification of DsbA-L relative to β-actin. ( H ) The activity of SOD in mice placenta. ( I ) The activity of GSH-Px in mice placenta. ( J ) The activity of CAT in mice placenta. ( K ) The content of MDA in mice placenta. HFD: high fat diet; AKT/PKB: protein kinase B; IRS1: insulin receptor substrate 1; STING: stimulator of interferon genes; DsbA-L: disulfide-bond A oxidoreductase-like protein; SOD: superoxide dismutase; GSH-Px: glutathione peroxidase; CAT: catalase; MDA: malondialdehyde. Data were shown as mean ± SD ( n ≥ 3). * P < 0.05; ** P < 0.01

Journal: Molecular Medicine

Article Title: Chemerin alleviates the placental oxidative stress and improves fetal overgrowth of gestational diabetes mellitus mice induced by high fat diet

doi: 10.1186/s10020-024-01007-2

Figure Lengend Snippet: The roles and mechanisms of chemerin in the placental oxidative stress and insulin resistance in HFD pregnant mice. ( A ) Western blotting images of mice placentas of three groups. ( B ) Western blotting images of mice placentas between the chow groups and the HFD groups. ( C ) Western blotting images of mice placentas between the HFD groups and the treated groups. The HFD placenta samples presented in ( B ) and ( C ) were from the same several mice. ( D ) Protein quantification of AKT relative to β-actin. ( E ) Protein quantification of IRS1 relative to β-actin. ( F ) Protein quantification of STING relative to β-actin. ( G ) Protein quantification of DsbA-L relative to β-actin. ( H ) The activity of SOD in mice placenta. ( I ) The activity of GSH-Px in mice placenta. ( J ) The activity of CAT in mice placenta. ( K ) The content of MDA in mice placenta. HFD: high fat diet; AKT/PKB: protein kinase B; IRS1: insulin receptor substrate 1; STING: stimulator of interferon genes; DsbA-L: disulfide-bond A oxidoreductase-like protein; SOD: superoxide dismutase; GSH-Px: glutathione peroxidase; CAT: catalase; MDA: malondialdehyde. Data were shown as mean ± SD ( n ≥ 3). * P < 0.05; ** P < 0.01

Article Snippet: Fasting insulin levels were measured using a mouse insulin ELISA kit (P01325, RayBiotech Life, USA) and the content of chemerin was assayed by the mouse chemerin ELISA kit (EK1330, Boster Biological Technology, China), assays were both according to the manufacturer’s protocols.

Techniques: Western Blot, Activity Assay

The long-term impacts of chemerin on blood glucose levels and body weight of maternal and fetal mice. ( A ) The postpartum blood glucose levels of the maternal mice at 8 weeks by IPGTT. ( B ) The blood glucose levels of the mice offspring at 8 weeks old by IPGTT. ( C ) The serum levels of chemerin in the maternal mice at 8 weeks after delivery. ( D ) The serum levels of chemerin in the mice offspring at 8 weeks old. ( E ) The changes of body weight of the mice offspring from 1 to 8 weeks of age. HFD: high fat diet. Data were shown as mean ± SD ( n ≥ 3). * P < 0.05; ** P < 0.01; *** P < 0.001

Journal: Molecular Medicine

Article Title: Chemerin alleviates the placental oxidative stress and improves fetal overgrowth of gestational diabetes mellitus mice induced by high fat diet

doi: 10.1186/s10020-024-01007-2

Figure Lengend Snippet: The long-term impacts of chemerin on blood glucose levels and body weight of maternal and fetal mice. ( A ) The postpartum blood glucose levels of the maternal mice at 8 weeks by IPGTT. ( B ) The blood glucose levels of the mice offspring at 8 weeks old by IPGTT. ( C ) The serum levels of chemerin in the maternal mice at 8 weeks after delivery. ( D ) The serum levels of chemerin in the mice offspring at 8 weeks old. ( E ) The changes of body weight of the mice offspring from 1 to 8 weeks of age. HFD: high fat diet. Data were shown as mean ± SD ( n ≥ 3). * P < 0.05; ** P < 0.01; *** P < 0.001

Article Snippet: Fasting insulin levels were measured using a mouse insulin ELISA kit (P01325, RayBiotech Life, USA) and the content of chemerin was assayed by the mouse chemerin ELISA kit (EK1330, Boster Biological Technology, China), assays were both according to the manufacturer’s protocols.

Techniques: